Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTR7 | P34969 | 1/20 | 0.36 |
| ▸ | NQO2 | P16083 | 2/20 | 0.33 |
| ▸ | MTNR1A | P48039 | 2/20 | 0.33 |
| ▸ | MTNR1B | P49286 | 2/20 | 0.33 |
| ▸ | RXRA | P19793 | 1/20 | 0.31 |
| ▸ | RXRB | P28702 | 1/20 | 0.31 |
| ▸ | RXRG | P48443 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9985162 | 0.81 | HTR7 (0.40) | HTR7NQO2MTNR1AMTNR1BRXRA | |
| SCHEMBL4970470 | 0.71 | RXRA (0.31) | RXRARXRBRXRG | |
| SCHEMBL12043859 | 0.71 | NQO2 (0.36) | HTR7NQO2MTNR1AMTNR1B | |
| SCHEMBL6909595 | 0.69 | RXRA (0.61) | RXRARXRBRXRG | |
| SCHEMBL8158082 | 0.69 | RARB (0.40) | RXRARXRBRXRG | |
| SCHEMBL29401105 | 0.67 | RXRA (0.41) | RXRARXRBRXRG | |
| SCHEMBL5009416 | 0.67 | RXRA (0.41) | RXRARXRBRXRG | |
| Lithium SCHEMBL29602414 | 0.66 | RXRA (0.40) | RXRARXRBRXRG | |
| SCHEMBL11240978 | 0.65 | CYP26B1 (0.51) | RXRARXRBRXRG | |
| SCHEMBL8450973 | 0.64 | MPO (0.33) | RXRARXRBRXRG |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8383848-B2 | Transition metal compound and catalyst for olefin polymerization | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2013-02-26 | — | — | US | disclosed |
| US-20110319578-A1 | TRANSITION METAL COMPOUND AND CATALYST FOR OLEFIN POLYMERIZATION | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2011-12-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110319578-A1 | TRANSITION METAL COMPOUND AND CATALYST FOR OLEFIN POLYMERIZATION | AP1M1, SOD1, YAP1 | HTR7 4438/4885NQO2 4666/4885MTNR1A 4031/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.